Investing

Novartis : NVS

NVS

Stock Data

$146.57

$1.28 (0.87%)

Asset Type

Common Stock

Exchange

NYSE

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DRUG MANUFACTURERS - GENERAL

Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.

All Novartis Articles

134 Articles

Michael Williams | Mar 28, 2026 at 7:15 AM EDT

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

VanEck Pharmaceutical ETF (NYSEARCA:PPH) exists to give investors broad exposure to the global pharmaceutical industry without the binary risk of…

John Seetoo | Mar 24, 2026 at 10:03 AM EDT

There Are Three Things Driving Amplify’s 5.1%. Yield Higher | IDVO

Most income ETFs draw from a single well: either dividends or options premium. The Amplify CWP International Enhanced Dividend Income…

David Beren | Jan 10, 2026 at 9:41 AM EST

Healthcare Dividend Stocks: The Recession-Proof Income Play for 2026

If a recession were to hit, it’s a foregone conclusion that people won’t stop taking their prescriptions, and they won’t…

Trey Thoelcke | Feb 14, 2025 at 8:45 AM EST

AbbVie Just Paid Investors: Here’s How Much They Received

AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50…

Trey Thoelcke | Jan 26, 2024 at 9:49 AM EST

How Safe Is AbbVie Stock’s 3.7% Dividend?

Here is an assessment of how safe the dividend at AbbVie appears to be based on a variety of metrics,…

Lee Jackson | Jan 6, 2024 at 9:10 AM EST

7 Rock-Solid Healthcare Dividend Stocks to Buy in January

Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest…

Lee Jackson | Dec 11, 2023 at 10:48 AM EST

6 Health Care Dividend Stocks to Buy Hand Over Fist

While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors…

Lee Jackson | Sep 29, 2023 at 7:15 AM EDT

The US Stock Market Could Crack in October: 6 ‘Strong Buy’ European Dividend Aristocrats to Buy Now

Here are six European Dividend Aristocrats that are the most liquid and well-known for U.S. investors who are looking for…

Lee Jackson | Apr 13, 2023 at 7:10 AM EDT

5 European Dividend Aristocrats Offer Huge Growth and Income Potential With Diversification From the US

For growth and income investors, adding top-quality dividend stocks based in Europe to domestic portfolios may be a solid way…

Lee Jackson | Apr 12, 2023 at 7:14 AM EDT

Why 7 of the Highest-Yielding ‘Strong Buy’ Health Care Stocks Are the Absolute Best 2023 Buys

With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking…

Lee Jackson | Jun 23, 2022 at 7:35 AM EDT

Why These 5 European Dividend Aristocrats (Some With Huge Yields) Are Incredible Q3 Buys

In what could be a long and brutal bear market in the United States, it may make sense for investors…

Chris Lange | May 9, 2022 at 2:28 PM EDT

From Bad to Worse and Then Some: Analysts Upgrade or Downgrade Domino’s, iHeartMedia, Match Group, Virgin Galactic and More

Monday’s additional top analyst upgrades and downgrades were on Domino’s, iHeartMedia, Match Group, Virgin Galactic and more.

Paul Ausick | Jan 31, 2022 at 1:27 PM EST

Earnings Previews: AbbVie, Humana, Marathon Petroleum, Novartis

We have previewed here three big health care companies, along with the country's largest oil refiner and marketer.

Lee Jackson | Dec 15, 2021 at 8:48 AM EST

Wednesday’s Top Analyst Upgrades and Downgrades: Albertsons, eBay, Freeport-McMoRan, GameStop, Melco Resorts, Nike, Novartis and More

Wednesday’s early top analyst upgrades and downgrades included Albertsons, AppLovin, Array Technologies, eBay, Freeport-McMoRan, GameStop, Melco Resorts, Navitas Semiconductor, Nike…

Lee Jackson | Dec 9, 2021 at 7:35 AM EST

Biotech Has Been Crushed: 5 Stocks to Buy Now That Pay Big Dividends

Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of…